Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
<p><b>Background</b></p> Sodium–glucose co-transporter-2 (SGLT2) inhibitors have been proposed as a potential treatment for adults hospitalised with COVID-19, due to their potential anti-inflammatory and endothelial protective effects. Published evidence from randomised contr...
Main Authors: | Vale, C, Godolphin, PJ, Fisher, D, Horby, PW, Kosiborod, MN, Hochman, JS, Webster, K, Higgins, JPT, Althouse, AD, Berwanger, O, Furtado, RHM, Gasparyan, SB, Haynes, R, Koch, GG, Landray, M, Leifer, E, Marshall, J, Murthy, S, Neal , M, Staplin, N, Diaz, J, Sterne, JAC, Shankar-Hari, M |
---|---|
Other Authors: | WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group |
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2024
|
Similar Items
-
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
by: Shankar-Hari, M, et al.
Published: (2021) -
Allocated but not treated: the silent 16% – Authors' reply
by: Horby, P, et al.
Published: (2022) -
Malnutrition in hospitalised children.
by: Sullivan, P
Published: (2010) -
Hospitalisation as an outcome measure in schizophrenia
by: Burns, T
Published: (2007) -
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, PW, et al.
Published: (2023)